<DOC>
	<DOCNO>NCT02402452</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics , safety , tolerability GS-9857 adult severe renal impairment match healthy control adult .</brief_summary>
	<brief_title>Pharmacokinetics GS-9857 Adults With Normal Renal Function Severe Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>All individual : Screening laboratory value within defined threshold group Use two effective contraception method female childbearing potential sexually active male For individual severe renal impairment : Stable chronic kidney disease Creatinine clearance ( CLcr ) &lt; 30 mL/min All individual : Pregnant nursing female male pregnant female partner Hepatitis B virus , hepatitis C virus ( HCV ) HIV infection History clinically significant illness medical disorder may interfere individual 's treatment , assessment compliance protocol For individual severe renal impairment : Anticipated require dialysis within 90 day study dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>